Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

被引：0
|
作者：
Toshirou Nishida
Kuniaki Shirao
Akira Sawaki
Masato Koseki
Takeshi Okamura
Atsushi Ohtsu
Toshiro Sugiyama
Kunihisa Miyakawa
Seiichi Hirota
机构：
[1] Osaka University Graduate School of Medicine,Department of Surgery
[2] National Cancer Center Hospital,Department of Medical Oncology
[3] Aichi Cancer Center Hospital,Department of Gastroenterology
[4] National Hospital Organization Kure Medical Center,Department of Surgery
[5] National Kyushu Cancer Center,Department of Gastroenterological Surgery
[6] National Cancer Center Hospital East,Division of Gastrointestinal Oncology/Digestive Endoscopy
[7] Hokkaido University Graduate School of Medicine,Department of Gastroenterology
[8] National Cancer Center Hospital,Diagnostic Radiology Division
[9] Hyogo College of Medicine,Department of Surgical Pathology
来源：
International Journal of Clinical Oncology | 2008年 / 13卷
关键词：
Gastrointestinal stromal tumor; Imatinib; Phase II;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
    Nishida, Toshirou
    Shirao, Kuniaki
    Sawaki, Akira
    Koseki, Masato
    Okamura, Takeshi
    Ohtsu, Atsushi
    Sugiyama, Toshiro
    Miyakawa, Kunihisa
    Hirota, Seiichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (03) : 244 - 251
  • [2] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Sawaki, A
    Yamao, K
    Nakamura, T
    Suzuki, T
    Okubo, K
    Hara, K
    Kawai, H
    Yamamura, Y
    Ito, S
    Mochiduki, Y
    Ohno, R
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 329 - 333
  • [3] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Akira Sawaki
    Kenji Yamao
    Tsuneya Nakamura
    Takashi Suzuki
    Kenji Okubo
    Kazuo Hara
    Hiroki Kawai
    Yoshitaka Yamamura
    Seiji Ito
    Yoshinari Mochiduki
    Ryuzo Ohno
    Journal of Gastroenterology, 2004, 39 : 329 - 333
  • [4] Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study
    van Oosterom, AT
    Judson, I
    Verweij, J
    Stroobants, S
    di Paola, ED
    Dimitrijevic, S
    Martens, M
    Webb, A
    Sciot, R
    Van Glabbeke, M
    Silberman, S
    Nielsen, OS
    LANCET, 2001, 358 (9291): : 1421 - 1423
  • [5] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 472 - 480
  • [6] Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
    Sawaki, Akira
    Yamada, Yasuhide
    Komatsu, Yoshito
    Kanda, Tatsuo
    Doi, Toshihiko
    Koseki, Masato
    Baba, Hideo
    Sun, Yu-Nien
    Murakami, Koji
    Nishida, Toshirou
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (05) : 961 - 967
  • [7] Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
    Akira Sawaki
    Yasuhide Yamada
    Yoshito Komatsu
    Tatsuo Kanda
    Toshihiko Doi
    Masato Koseki
    Hideo Baba
    Yu-Nien Sun
    Koji Murakami
    Toshirou Nishida
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 961 - 967
  • [8] Phase II study of imatinib mesylate (ST1571) for patients with recurrent meningiomas (NABTC 01-08)
    Wen, P. Y.
    Yung, W. K. A.
    Lamborn, K.
    Cloughesy, T.
    DeAngelis, L. M.
    Fine, H. A.
    Chang, S. M.
    Robins, H. I.
    Fink, K.
    Abrey, L. E.
    Lassman, A. B.
    Mehta, M.
    Kesari, S.
    Kim, L.
    Stiles, C.
    Egorin, M.
    Kaplan, R.
    Murgo, A.
    Prados, M. D.
    NEURO-ONCOLOGY, 2006, 8 (04) : 454 - 454
  • [9] Phase II clinical study of ST1571 in Japanese (Jpn) patients (pts) with malignant gastrointestinal stromal tumors (GIST): Results of the B1201 study.
    Doi, T
    Nishida, T
    Hirota, S
    Sugiyama, T
    Yamao, K
    Koseki, M
    Okamura, T
    Shirao, K
    Ohtsu, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 332S - 332S
  • [10] Update of phase I study of imatinib (ST1571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
    van Oosterom, AT
    Judson, IR
    Verweij, J
    Stroobants, S
    Dumez, H
    di Paola, ED
    Sciot, R
    Van Glabbeke, M
    Dimitrijevic, S
    Nielsen, OS
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S87
12345